Aytu Biopharma (AYTU) EPS (Basic) Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) EPS (Basic) Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.87% |
| Mar 31, 2025 | 14.87% |
| Dec 31, 2024 | 14.87% |
| Sep 30, 2024 | 14.88% |
| Jun 30, 2024 | 72.11% |
| Mar 31, 2024 | 74.44% |
| Dec 31, 2023 | 74.62% |
| Sep 30, 2023 | 80.29% |
| Jun 30, 2023 | 77.83% |
| Mar 31, 2023 | 76.22% |
| Dec 31, 2022 | 77.89% |
| Sep 30, 2022 | 87.01% |
| Jun 30, 2022 | 14.87% |
| Mar 31, 2022 | 74.90% |
| Dec 31, 2021 | 82.04% |
| Sep 30, 2021 | 81.65% |
| Jun 30, 2021 | 87.37% |
| Dec 31, 2020 | 85.48% |
| Sep 30, 2020 | 86.39% |
| Jun 30, 2020 | 82.82% |